0
A major new mesothelioma study suggests that adding a third drug to the standard two-drug chemotherapy combination has the potential to extend mesothelioma survival.(PRWeb January 23, 2016)Read the full story at http://www.prweb.com/releases/2016/01/prweb13177751.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.



from MedWorm: Mesothelioma http://www.medworm.com/index.php?rid=163439285&cid=c_409_34_f&fid=22564&url=http%3A%2F%2Fwww.prweb.com%2Freleases%2F2016%2F01%2Fprweb13177751.htm
ad

Enregistrer un commentaire

 
Top